SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277136
Filing Date
2023-11-14
Accepted
2023-11-14 16:25:53
Documents
14
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d309650d8k.htm   iXBRL 8-K 25885
2 EX-99.1 d309650dex991.htm EX-99.1 14233
6 GRAPHIC g309650g1115004613077.jpg GRAPHIC 4402
  Complete submission text file 0001193125-23-277136.txt   173313

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20231114.xsd EX-101.SCH 2873
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20231114_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20231114_pre.xml EX-101.PRE 11277
8 EXTRACTED XBRL INSTANCE DOCUMENT d309650d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 231406834
SIC: 2834 Pharmaceutical Preparations